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Summary: In this work we present a method suitable to quantify 17 mercapturic acids, which are 
urinary metabolites of toxicants. This method was subjected to a complete validation and a first 
application was carried out on urine samples derived from petrochemical workers. 
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Introduction 
Mercapturic acids are metabolic end products of 
some occupational and environmental toxicants 
such as volatile organic compounds. They are 
metabolites formed by the conjugation of an 
electrophilic compound with glutathione. These 
electrophilic metabolic intermediates are 
believed to be the active species able to react 
with DNA and responsible for the genotoxicity 
associated with parent compounds [1]. 
Mercapturates can be found in urine and, 
therefore, they can be considered useful non-
invasive biomarkers of exposure. Although 
several analytical methods were reported for the 
analysis of single or small groups of 
mercapturates [2], only two papers describes 
the analysis of several mercapturates [3,4]. The 
aim of this work was to set up a LC-MS/MS 
method able to determine mercapturic acids 
derived from different toxicants. 
 
Experimental 
For the preparation of standard solution, the 
majority of standard compounds were 
purchased from Toronto Research Chemicals 
(Ontario, Canada), along with relative 
isotopically labelled standards. The complete 
list of analytes is reported in Table 1. The 
simple sample preparation developed includes 
dilution with formic acids (0.2 M), addition of 
an internal standard mixture of 16 deuterated 
analogs and filtration with 0.45 µm regenerated 
cellulose membrane filter (Agilent 
Technologies, Santa Clara, California).  
 
 
Table 1. List of considered analytes 
Investigated 
analytes 
Parent compounds 
2-HPMA propylene oxide 
3-HPMA acrolein 
AAMA acrylamide 
AMCC N,N-dimethylformamide 
CEMA acrylonitrile 
CMEMA crotonaldehyde 
EMA ethylating agents 
GAMA acrylamide 
HEMA alkylating agents 
HMPMA crotonaldehyde 
M1 1,3-butadiene 
M2 1,3-butadiene 
MMA Methylating agents 
NANPC 4-chloronitrobenze 
PHEMA1+2 styrene 
SBMA toluene 
SPMA benzene 
 
Analysis were carried out using a hybrid triple 
quadrupole/linear ion trap mass spectrometer 
(QTRAP 5500, AB Sciex, Monza, Italy) 
interfaced with an ultrahigh pressure liquid 
chromatograph (UHPLC, Agilent 1220, 
Cernusco sul Naviglio, Italy) equipped with a 
Betasil C18 column (150 x2.1 mm, 5 µm; 
Thermo Fisher Scientific, Rodano, Italy) and a 
pre-column BETASIL C18 (10 x 2,1 mm, 5µ; 
Thermo Fisher Scientific, Rodano, Italy). 
Chromatographic separation was performed 
using a linear gradient with an aqueous mobile 
phase composed by an aqueous solution of 
ammonium formiate 5 mM and 0.1% formic 
acid and an organic mobile phase composed by 
acetonitrile. 
A complete validation was carried out: 
linearity, sensitivity, accuracy, precision, 
selectivity, matrix effect, recovery and process 
efficiency were evaluated according to both 
FDA guidelines and the considerations reported 
in the review written by González and co-
workers [5,6]. 
The method was then applied to the analysis of 
urine samples from adult subjects with different 
smoking habits: non-smokers, electronic 
cigarette smokers, and traditional tobacco 
smokers. 
 
Results 
Results from linearity assays showed that 
correlation coefficients (R2) were close to 1 for 
most of compounds, demonstrating optimal 
linear responses for the considered 
concentrations ranges, although a polynomial 
regression was necessary for AAMA since it 
showed a saturation at high concentrations. 
Limits of quantitation (LOQ) values were 
between 0.15 and 1 µg/L, except for HEMA 
and AAMA (1.93 and 1.30 µg/L 
respectively). Precision, evaluated as 
relative standard deviations (RDS), was below 
15% for most analytes in both intra-day and 
inter-day tests. Accuracy was between 85 and 
110 % of expected values, with few exceptions 
exceeding 120% at the lowest concentrations. 
Selectivity was verified by injection of a blank 
sample (synthetic urine) showing no 
chromatographic peak having an area at 20% of 
LOQ at the relative retention time and mass 
transition of compounds of interest. The same 
condition was verified analysing a blank sample 
immediately after the injection of the standard 
mixture at the highest concentration of the 
calibration curve, indicating the absence of 
carry-over. Results from the matrix effect, 
recovery and process efficiency tests were 
suitable in most of the cases, with some 
exceptions that were partially corrected using 
the internal standards. 
Results from urine samples of individuals with 
different smoking habit showed significant 
differences between smokers and non-smokers: 
11 different mercapturic acids were 
significantly higher (P-value ≤0.005) in 
traditional tobacco smokers than in non-
smokers (an example is illustrated in Figure 1). 
 
 
Fig. 1. Box-plot illustrating differences between 
non-smokers, electronic cigarette smokers and 
traditional tobacco smokers for 2-HPMA 
(mercapturic acid of propylene oxide). 
 
Conclusion 
In this work, we developed a method useful to 
quantify mercapturic acids in urine samples. 
The method was subjected to a complete 
validation and showed to be suitable for most of 
the considered analytes. Despite some critical 
issues with some analytes (in particular 
HEMA), it demonstrated to be an useful tool for 
fast determination of mercapturates. The first 
application carried out using human urine 
samples suggests that mercapturic acids are 
suitable biomarkers for toxicants in tobacco 
smoke. 
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